Skip to content
sahil.science
Questions
Papers
Topics
Syntheses
Almanac
About
C⁶
2026
← Questions
Source-derived question
How do the CTLA-4 and PD-1 checkpoints let tumours suppress an immune attack?
Immunology
Targeted Cancer Therapy
Sources that address it
Cancer immunotherapy named Science's Breakthrough of the Year
almanac
Related questions
How did checkpoint inhibitor drugs change outcomes for patients with metastatic melanoma?
How do modern vaccines and targeted cancer therapies draw on both Mechnikov's and Ehrlich's discoveries?
How does fusing a spleen cell with a myeloma cell produce a hybridoma that manufactures one antibody forever?
How does the Y-shaped antibody model inform the design of modern monoclonal antibody drugs?
What downstream medical practices, like cancer immunotherapy and vaccine design, depend on this principle of self-plus-foreign recognition?
What made the 2013 clinical trial results in metastatic melanoma different from prior cancer treatments?
Why did Science call checkpoint blockade a new category of treatment rather than just a new drug?
Why does the immune system often fail to attack tumours even after T cells infiltrate them?